Evolent Health Inc - Ordinary Shares - Class A
EVH
Get informed when a big investor buys or sells
+ FollowMarket Cap$471.3M
Close$
$8.58
104.8% upside
Current Fair Value
104.8% upsideUndervalued by 104.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $471.30 Million |
|---|---|
| Enterprise Value | $360.77 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.07 |
| Beta | 0.84 |
| Outstanding Shares | 112,542,000 |
Return
| Return on Equity | -133.36% |
|---|---|
| Return on Assets | -25.92% |
| Return on Invested Capital | -34.19% |
Valuation & Multiples
| P/E Ratio | -0.93 |
|---|---|
| PEG | 2.1 |
| Price to Sales | 0.3 |
| Price to Book Ratio | 1.4 |
| Enterprise Value to Revenue | 0.22 |
| Enterprise Value to EBIT | -0.71 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$597.69 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$728.57 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.3363▼ 15.47% |
|---|---|
| Total Calls | 179,300▲ 89.33% |
| Total Puts | 239,600▲ 69.69% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 101.68%▲ 2.69% |
|---|---|
| Total Invested | $619.90M▲ 145.24% |
| Investors Holding | 207▲ 10.00% |
ESG Score
No data
About Evolent Health Inc
CEO: Frank Williams